In response to the COVID-19 pandemic, vaccines for SARS-CoV-2 were developed, tested,
and introduced at a remarkable speed. Although the vaccine introduction had a major …

Importance The COVID-19 pandemic saw one of the fastest developments of vaccines in an
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine …

Abstract Severe coronavirus disease 2019 (COVID-19) is characterized by an increased risk
of thromboembolic events, a leading cause for adverse outcomes in patients afflicted by the …

Background Antiplatelet and antithrombotic medication management before, during, and
after neurointerventional procedures has significant practice variation. This document …

To date, billions of vaccine doses have been administered to restrain the current COVID-19
pandemic worldwide. Rare side effects, including intravascular blood clots, were reported in …

Background: Cerebral venous sinus or vein thromboses (SVT) are treated with heparin
followed by oral anticoagulation. Even after receiving the best medical treatment, numerous …

Cerebral venous sinus thrombosis (CVST) is a rare cerebrovascular disorder predominantly
observed in adults, but can pose unique challenges in pediatric patients. 1 The underlying …

Purpose We reported the first described post Ad26. COV2. S (Janssen, Johnson & Johnson)
vaccine-induced immune thrombocytopenia (VITT) case outside US. Case description CA …

Objective Cerebral venous sinus thrombosis (CVST) is increasingly being recognized in the
setting of traumatic brain injury (TBI), but its effect on TBI patients and its management …

Cerebrovascular injuries resulting from blunt or penetrating trauma to the head and neck
often lead to local hemorrhage and stroke. These injuries present with a wide range of …